CNE000000D16
CNE000000D16
NORTH CHINA PHARMACEUTICAL CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 9.241.652.954 | 9.869.575.819 | 6.4% |
| Cost of Revenue | 6.376.291.488 | 6.714.658.593 | 5.0% |
| Gross Profit | 2.865.361.466 | 3.154.917.226 | 9.2% |
| 2.199.803.620 | 2.425.020.792 | 9.3% | |
| Operating Income | 665.557.846 | 729.896.434 | 8.8% |
| Pretax Income | 357.408.948 | 309.832.513 | 15.4% |
| Net Income Common Stockholders | 183.056.161 | 126.992.370 | 44.1% |
| -- | -- | -- | |
| -- | -- | -- |